Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Aura Biosciences, Inc. (AURA)

NASDAQ

$6,94

$--

(0,00%)

Pre-Market

Aura Biosciences, Inc. (AURA) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Aura Biosciences, Inc. (AURA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6,94, with a market capitalisation of $726,97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,73 to $9,54. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$726,97M
Open	$6,94
Day's High	$26,16
Day's Low	$4,35
Previous Close	$6,92
Volume	317,00
Average Volume	665,75K
P/E Ratio	--
52-Week High	$9,54
52-Week Low	$4,73
Dividend Yield	--
Earnings Date	--

Aura Biosciences, Inc. (AURA) Pre-Market Stock Price

Aura Biosciences, Inc. (AURA) is trading at $6,94 in pre-market trading as of 2026-09-16 08:51:00, up 0,29% ($0,02) from the previous close of $6,92

Pre-market trading shows how investors are pricing AURA before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Aura Biosciences, Inc. (AURA) 7-Day Stock Price Change

Over the past seven days, Aura Biosciences, Inc. (AURA) moved from $7,56 to $6,94, representing a decline of 8,20% ($0,62).

The stock traded between $6,61 and $7,57 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 603,73 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

AURA 52-Week Price Position

Position in Range: 46,0%

52W Low$4,73

52W High$9,54

AURA is currently trading at $6,94, placing it 46,0% of the way from its 52-week low of $4,73 to its 52-week high of $9,54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aura Biosciences, Inc. (AURA)?

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Aura Biosciences, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	113
Exchange	NASDAQ
Company Website	https://www.aurabiosciences.com

How to Buy Aura Biosciences, Inc. (AURA) Stock on MEXC

Eligible investors can buy real shares of Aura Biosciences, Inc. (AURA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AURA and Place Your Order

Open the RealStocks trading page and search for AURA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aura Biosciences, Inc. (AURA) stock price today?

Aura Biosciences, Inc. (AURA) is currently trading at $ 6,94, up 0,29% ($0,02) from the previous close of $ 6,92. Intraday prices update in real time during regular trading hours.

2.Is AURA stock going up or down today?

As of 2026-09-16 08:51:00, AURA is trading at $ 6,94, up 0,29% ($0,02) from its previous close of $ 6,92. The stock has traded between $ 4,35 and $ 26,16 during today’s regular session. Past price movements do not guarantee future results.

3.What is AURA pre-market price?

As of 2026-09-16 08:51:00, AURA is trading at $ 6,94 in pre-market trading, up 0,29% ($0,02) from the previous close of $ 6,92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AURA after-hours price?

As of 2026-09-16 08:51:00, AURA is trading at $ 6,94 in after-hours trading, up 0,29% ($0,02) from the regular-session close of $ 6,92. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AURA stock trading now?

AURA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AURA sit relative to its 52-week high and low?

Over the past 52 weeks, AURA has traded between a low of $ 4,73 and a high of $ 9,54. At $ 6,94, the stock is positioned 46,0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aura Biosciences, Inc. in?

Aura Biosciences, Inc. (AURA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aura Biosciences, Inc.'s market capitalisation and where is it listed?

Aura Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 726,97M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AURA valued in terms of P/E ratio and EPS?

AURA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,26. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aura Biosciences, Inc. pay a dividend?

Aura Biosciences, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.